BDX

Becton Dickinson and Co
D

BDX

Arincen48/100B
218.070
USD
2.34
(1.08%)
Market Closed
Last updated: · Delayed 15 min
Fair value334.36Plus-35%251Price 218.07418
Q1 FY2027 · Earnings report
EPS estimate 2.35Revenue estimate 4.50B
OverviewFinancialsForecastEarningsDividendsCompany

Becton Dickinson and Co revenue 1985–2026

Becton Dickinson and Co's revenue in Q4 FY2026, the three months to 30 September 2026, was 5.27B USD, down 10.5% on the same quarter a year before. Becton Dickinson and Co's revenue over the last twelve months was 19.46B USD, down 10.9% on the twelve months before. In fiscal year 2026 it was 19.46B USD, down 10.9% on the year before.

Last updated 10 Nov 2026 · Next report 8 Feb 2027

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM30 Sept 202619.46B-10.91%9.21B1.15B
FY202630 Sept 202619.46B-10.91%9.21B1.15B
FY202530 Sept 202521.84B+8.23%9.92B1.68B
FY202430 Sept 202420.18B+4.16%9.13B1.71B
FY202330 Sept 202319.37B+2.66%8.17B1.48B
FY202230 Sept 202218.87B-1.36%8.48B1.78B
FY202130 Sept 202119.13B+19.02%8.63B2.09B
FY202030 Sept 202016.07B-7.03%6.80B874.00M
FY201930 Sept 201917.29B+8.18%8.29B1.23B
FY201830 Sept 201815.98B+32.17%7.27B311.00M
FY201730 Sept 201712.09B-3.12%5.97B1.10B
FY201630 Sept 201612.48B+21.41%5.99B976.00M
FY201530 Sept 201510.28B+21.74%4.70B695.00M
FY201430 Sept 20148.45B+4.87%4.30B1.19B
FY201330 Sept 20138.05B+4.49%4.17B1.29B
FY201230 Sept 20127.71B+1.64%3.95B1.17B
FY201130 Sept 20117.58B+6.45%3.96B1.27B
FY201030 Sept 20107.12B+1.97%3.70B1.32B
FY200930 Sept 20096.99B-1.25%3.68B1.23B
FY200830 Sept 20087.07B+11.25%3.63B1.13B
FY200730 Sept 20076.36B+10.83%3.29B890.03M
FY200630 Sept 20065.74B+5.97%2.94B752.28M
FY200530 Sept 20055.41B+9.73%2.75B722.26M
FY200430 Sept 20044.93B+10.56%2.43B467.40M
FY200330 Sept 20034.46B+12.70%2.17B547.06M
FY200230 Sept 20023.96B+5.49%1.91B479.98M
FY200130 Sept 20013.75B+3.76%1.84B401.65M
FY200030 Sept 20003.62B+5.85%2.06B392.90M
FY199930 Sept 19993.42B+9.67%1.97B275.70M
FY199830 Sept 19983.12B+10.90%1.80B236.60M
FY199730 Sept 19972.81B+1.47%1.61B300.10M
FY199630 Sept 19962.77B+2.11%1.54B283.60M
FY199530 Sept 19952.71B+5.98%1.48B251.70M
FY199430 Sept 19942.56B+3.82%1.36B227.20M
FY199330 Sept 19932.47B+4.23%1.29B71.70M
FY199230 Sept 19922.37B+8.89%1.23B200.80M
FY199130 Sept 19912.17B+7.92%1.15B189.80M
FY199030 Sept 19902.01B+11.11%1.06B182.30M
FY198930 Sept 19891.81B+5.97%950.30M168.90M
FY198830 Sept 19881.71B+8.05%904.30M162.00M
FY198730 Sept 19871.58B+20.62%819.30M141.80M
FY198630 Sept 19861.31B+14.67%684.80M111.90M
FY198530 Sept 19851.14B—577.60M88.00M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Becton Dickinson and Co revenue growth by segment

Q1 FY2026 against Q1 FY2025

Life Sciences2.50B
+92.8%
Medical2.40B
-8.2%

Becton Dickinson and Co revenue by segment over time

Medical Interventional Life Sciences
Fiscal yearMedicalInterventionalLife Sciences
FY202511.46B +13.7%5.22B +4.8%5.17B -0.5%
FY202410.07B +6.0%4.98B +5.2%5.19B +1.1%
FY20239.50B +7.5%4.74B +6.1%5.13B -7.7%
FY20228.84B -6.7%4.46B +5.3%5.56B -14.8%
FY20219.48B +9.2%4.24B +12.7%6.53B +39.7%
FY20208.68B -4.2%3.76B -4.2%4.68B +8.7%
FY20199.06B +5.2%3.93B +29.3%4.30B -0.7%
FY20188.62B +6.3%3.04B 4.33B +8.6%
FY20178.11B -6.3%— 3.99B +4.2%
FY20168.65B +34.0%— 3.83B +0.2%

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Becton Dickinson and Co's revenue

Source: Financial Modeling Prep